# Beijing Leiao Dingfeng Biotechnology

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/beijing-leiao-dingfeng-biotechnology

- Industry: Healthcare IT
- Headquarters: Beijing, China
- Latest round: Angel (Dec 5, 2022)
- Investors on record: 2

## About

Based in Beijing, China, and founded in 2022, Beijing Leiao Dingfeng Biotechnology is a healthcare company providing life science laboratory automation solutions. The founder, Lei Wang, has over 20 years of experience in life science, pharmaceutical research, and automation system research and marketing. In September 2023, the firm raised pre-series A funding led by new investor Sinopharm Capital. Other returning investor Huagai Capital also participated in the round.

The company is committed to providing systematic and intelligent products and solutions for R&D companies, AI pharmaceuticals, and CROs in the fields of innovative drugs, synthetic biology, and single-cell sequencing. It has developed the intelligent nanoliter-microscale pipetting workstation, which can help experimenters get rid of experimental operations and reduce human errors, improve the reproducibility and accuracy of experiments, and control and trace the process.

The company will use the pre-series Afunding for the industrialization of intelligent, nanoliter pipetting workstations and the delivery of system integration solutions.

## Funding rounds

- Angel, Dec 5, 2022 — Huagai Capital, CBC Group

## Investors

- Huagai Capital (https://capitalatlas.ai/funds/huagai-capital) — Angel
- CBC Group (https://capitalatlas.ai/funds/cbc-group) — Angel